Study of a blood test to guide radiation therapy after breast surgery
Part of Cancer, Skin clinical trials.
This study uses a special test (DCISionRT) on tissue from your breast surgery to help doctors decide if radiation therapy is right for you after lumpectomy for DCIS (a non-invasive form of breast cancer). The goal is to personalize treatment based on your individual cancer characteristics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 30 and 85 years old
- You have been diagnosed with DCIS (ductal carcinoma in situ) that is 6 cm or smaller
- You had breast-conserving surgery (lumpectomy) with clear surgical margins (at least 2 mm)
- Your surgery was within the last 70 days and your incision is well-healed with no infection
- You have no suspicious spots in either breast that haven't been biopsied and checked
- You can have a tissue sample tested with the DCISionRT test and are willing to follow study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single, targeted radiation treatment given during or after lumpectomy for early-stage breast cancer. It aims to make treatment more convenient while keeping the same safety and effectiveness as longer radiation courses.
This study records details about radiation delivered while your surgery is happening for certain early breast cancers or pre-cancers. It may help doctors better understand who benefits most from this “intra-operative” radiation approach.
This study collects information about people with early-stage, hormone-receptor–positive breast cancer who have a lumpectomy and radiation. It may help doctors understand outcomes after this standard treatment and improve care for future patients.
This trial is for women aged 55 or older with very early-stage breast cancer (stage 0 or 1) who want to save their breast. It tests giving a single dose of radiation during the lumpectomy instead of weeks of daily radiation afterward.
This trial studies whether a specific radiation approach after lumpectomy can be helpful for certain people with early breast cancer that did not spread to lymph nodes at diagnosis. It focuses on people who finish neoadjuvant (before-surgery) treatment and reach a full response on final pathology.
This trial studies a standard follow-up treatment plan that combines chemotherapy and radiation after surgery, and it looks for blood/tissue “biomarkers” that predict who benefits most. If you have high-risk breast cancer that didn’t fully disappear after initial (neoadjuvant) chemo, you may be eligible to help guide better future treatment choices.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.